clinical trial · NCT06649877
MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)
Merck Sharp & Dohme LLC·phase1·completed·n = 16
HealthyMK-6194
brief summary
The goal of this study is to learn what happens to MK-6194 in a healthy person's body when different injection sites are used. Researchers will compare what happens to MK-6194 in a healthy person's body when it is injected into the abdomen and when it is injected into the thigh. Researchers think that the average amount of MK-6194 in a person's body over time will be similar when injected into the thigh or abdomen. They also want to learn if it is safe to inject MK-6194 into the abdomen and thigh, and if people tolerate it.
started
Mar 20, 2023
primary completion
Jul 13, 2023
completion
Jul 13, 2023
last updated
Oct 21, 2024
official title
A Randomized Clinical Study to Evaluate the Impact of Injection Site (Thigh vs Abdomen) on the Pharmacokinetics and Relative Bioavailability of Subcutaneously Injected MK-6194 in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol